Maurice sat cross-legged on his favorite monitor, a spreadsheet of dividend history in one hand and a perfectly ripe banana in the other, nodding with the satisfied expression of someone who’d finally found what he was looking for.
Listen, I’ve spent years in this business watching stocks that promise the world and deliver about as much as a peeled banana — which is to say, not much. But every so often, you find something that actually does what it says it will do. Something reliable. Something that pays you just for showing up and being patient.
That’s Ares Capital Corporation (ticker: ARCC), and I need to tell you why I’ve stopped throwing bananas at my monitor in frustration and started carefully setting them aside in a neat pile instead.
Here’s the thing about dividend stocks: most people talk about them like they’re some kind of financial alchemy. “Just find a stock with a high yield and you’re set for life!” they chirp, usually right before the yield gets slashed by half and the stock price tanks. I’ve seen it happen more times than I’ve peeled bananas — which is a LOT.
But ARCC is different. It’s a Business Development Company (BDC), which means it’s legally required to distribute at least 90% of its taxable income to shareholders. It’s not optional. It’s not “we’ll do this when we feel like it.” It’s written into the structure like the potassium is written into my dietary requirements.
The current yield is sitting at 9.6%. That’s genuinely exceptional in this interest rate environment. And here’s where most investors mess up: they look at that number and think “too good to be true,” so they skip it. Me? I looked at it and immediately started digging into the fundamentals, because if something actually IS that good, I want to understand why, not assume it’s a trap.
What I found was almost boring in its consistency.
ARCC has been paying a quarterly dividend of $0.48 per share with remarkable stability. Think about that for a second. If you own 100 shares, you’re collecting $192 every quarter, or $768 a year, regardless of what the market is doing around you. At the current price of $17.99, that’s already north of $1,500 annually just from dividends. Scale that up to your actual portfolio size and suddenly we’re talking about real money.
The payout ratio — which is the percentage of earnings actually being distributed — sits at 1.03x. Now, that number might make some investors nervous because it’s slightly above 1.0, which technically means the company is paying out more than it earns. But here’s where I need to stop and explain why this matters less than you think it does.
BDCs are structured differently than regular corporations. They collect interest and fees on their portfolio of loans and investments. Some of that income is taxable to shareholders even though it’s not paid out in cash. So while the official “earnings” number might show a slight payout ratio above 1.0, the actual cash the company is generating is more than sufficient to cover the distribution. It’s like saying a banana smoothie has “too much banana” — technically possible, but in practice, you’re just getting a really good smoothie.
I spent a solid hour last Tuesday physically walking through ARCC’s portfolio strategy. The company specializes in lending to middle-market companies — the kind of businesses that are too big for traditional banks to care about but too small to tap the public markets easily. These are real companies with real cash flows. ARCC typically invests between $30 million and $500 million per deal, targeting companies with $10-250 million in EBITDA.
That’s a sweet spot. These aren’t moonshot tech companies that might be worth billions tomorrow or zero the day after. These are manufacturing firms, business services, healthcare, retail operations — the backbone of the actual economy. If you lend to a company making industrial bearings or managing IT services, you’re not betting on a miraculous future. You’re earning a steady return on a company that’s already profitable and operational right now.
Here’s what really caught my attention: the low beta of 0.627. That means when the market has a bad day and drops 10%, ARCC typically only drops about 6%. That’s genuine downside protection, not marketing language. During 2022 and 2023 when interest rates were rising, BDCs generally suffered because people assumed higher rates would hurt their loan portfolios. But ARCC’s conservative lending approach — they’re selective about underwriting — meant the company held up better than peers. The diversification of borrowers and the nature of their lending structures provided real shock absorption.
Now, let me address the elephant in the room: earnings growth. The data shows -24.9% earnings growth, which sounds alarming until you understand what’s happening. This is a year-over-year comparison in an environment where interest rates are higher and the lending market is tighter. But net income isn’t the right metric to obsess over here. What matters is whether the company can sustain its dividend distribution, and the answer is definitively yes.
The free cash flow generation is solid at $689 million. That’s real money the company can use to weather downturns, fund new investments, or maintain distributions. When you’re in a business built on extracting steady interest payments from loans, you don’t need explosive growth. You need reliability and consistency — which brings me back to my original observation: this is refreshingly boring in the best possible way.
The current stock price of $17.99 is actually attractive compared to the 52-week range of $17.40 to $23.42. We’re near the lower end of that range, which means you’re not buying at the euphoric top. Bully Bob’s entry point suggestion of $19.97 would give the stock a bit of breathing room above where we are now, and his target of $22.50 represents about a 25% appreciation potential ON TOP of the 9.6% yield you’re collecting along the way.
Let me do some math here because this is where it gets interesting. If you buy ARCC at $18 and it moves to $22.50 over the next 18-24 months, that’s a $4.50 gain per share. Meanwhile, you’re collecting dividends totaling roughly $0.96 per share (four quarterly payments of $0.24). Total return: about $5.46, or roughly 30% on your investment. That’s 30% including both price appreciation AND dividend income. Not bad for a “boring” BDC.
The market cap of $12.9 billion means this isn’t some tiny illiquid story. You can buy and sell shares without moving the market. There’s actually 13 analysts covering the stock with a consensus “buy” recommendation, and the analyst target price is $21.88 — right in line with Bully Bob’s thinking.
Now, I need to talk about the risks because I’m not the kind of monkey who ignores danger just because something smells sweet.
First: interest rate risk. If rates start dropping significantly, ARCC’s yields on new loans might be lower, which could pressure future earnings and potentially the dividend. That said, the company operates in an environment where rates are likely to stay sticky for a while, so this is a 2-3 year horizon risk, not an immediate threat.
Second: borrower performance. If the economy weakens and the middle-market companies in ARCC’s portfolio struggle to service their debt, it could impact distributions. However, the company’s track record through COVID and the 2022-2023 credit stress shows they’ve done the work to underwrite quality borrowers.
Third: the short ratio is 4.42%, which is moderate. Not dangerously high, but it’s worth monitoring. If shorts ever get crowded, a positive catalyst could squeeze the stock upward.
The one thing that caught me slightly off-guard was the debt-to-equity ratio of 111.9. That sounds insane until you remember that BDCs are specifically structured to use leverage to enhance returns. It’s not a red flag for ARCC; it’s essentially how the business model works. The company borrows money at lower rates and lends it out at higher rates, pocketing the spread. As long as the spread is maintained and borrowers pay on time, this leverage works beautifully in your favor.
Here’s my honest take: if you’re looking for capital appreciation fireworks, ARCC isn’t your stock. If you’re hunting for a company that will double in six months, go find a speculative biotech somewhere. But if you’re looking for a stock that will give you a 9%+ yield, protect your downside during market stress, and potentially provide 20-30% total returns over the next two years while you sleep soundly knowing you own stakes in profitable, operational businesses, then ARCC is worth serious consideration.
I’ve spent enough time in this market to know that a stock that actually does what it promises is rarer than a monkey who doesn’t love bananas. ARCC is that stock. It’s not flashy. It won’t make for great cocktail party conversation. But it will make you money, and it will do it reliably.
That’s worth setting aside your bananas for.
Trained Market Monkey 